John A III Stalfort

CIK 1709418 · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$23.34M

Companies

4

Total Filings

19

Lifetime Open-Market Net

$2.25M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ABOS Director 352,219 $2.37 $834.8K $560.0K 7 2026-06-05
TSHA Director 2,060,849 $5.71 $11.77M $700.0K 5 2026-06-02
VRCA Director 1,873,800 $5.73 $10.74M $796.8K 5 2024-11-26
Dova Pharmaceuticals Inc. (DOVA) Delisted Director 0 $194.1K 2 2019-11-12

Recent Filings · Page 2 of 2

19 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-07-05 VRCA Buy (P) +238,095 $500.0K EDGAR
2022-06-17 ABOS Grant (A) $0 EDGAR
2021-07-08 ABOS Mixed +296,775 $560.0K EDGAR
2021-07-02 ABOS Grant (A) $0 EDGAR
2020-08-17 VRCA Buy (P) +31,250 $200.5K EDGAR
2019-11-12 Dova Pharmaceuticals Inc. (DOVA) Delisted U −635,665 -$17.48M EDGAR
2019-01-07 VRCA Buy (P) +9,221 $96.4K EDGAR
2018-12-21 Dova Pharmaceuticals Inc. (DOVA) Delisted Buy (P) +31,000 $194.1K EDGAR
2018-06-19 VRCA Conv (C) +394,295 $0 EDGAR
Showing 1119 of 19
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.